Antithrombotics Antiplatelets Flashcards
Antidote of Dabigatran
Idarucizumab
Non valvular Afib means
AF in absence of RHD,Prosthetic valve, MVrepair- ACC AHA 2011
Exclusion criteria in RELY trial
Prosthetic valve or hemodynamically relevant valve disease
In ROCKET AF-Prosthetic valve Or significant MS excluded
ARISTOTLE-Moderate to Severe MS and Prosthetic valve excluded
DRA in that order
Interaction b/w Digoxin and Amiodarone
Increases Digoxin levels
Reduce dose by 50%
Interaction b/w Digoxin And Warfarin
Digoxin increases INR
Food increases the bioavailability of which NOAC
Rivaroxaban -with food 100% and without 66%
Half life of Alteplase
3-4 mts
The tissue plasminogen activator is
rTPA- Alteplase
Reteplase is nonglycosylated form of rTPA- it is known as rPA
Tenecteplase is a multipoint (3 point mutations) mutant of rTPA has longer half life
Half life of Alteplase
3-4 mts
The tissue plasminogen activator is
rTPA- Alteplase
Reteplase is nonglycosylated form of rTPA- it is known as rPA
Tenecteplase is a multipoint mutant of rTPA has longer half life
Half life of Alteplase
3-4 mts
The tissue plasminogen activator is
rTPA- Alteplase
Reteplase is nonglycosylated form of rTPA- it is known as rPA
Tenecteplase is a multipoint mutant of rTPA has longer half life
USPSTF recommends Aspirin for
> 50 yrs with >10% risk
Non thienopyridine P2Y12 inhibitors
Ticagrelor, Cangrelor
Dabigatran phase 3 trial was published in
2009
NOAC indicated if CHADS2 Vasc score is
2
If score is 1 it can be considered
NOAC -Efficacy wise best p value is…
Safety wise best p value is….
Dabigatran
Safety- Apixaban
4 studies on NOAC plus anti platelet
- PIONEER AF PCI- Rivoroxaban
- RE -DUAL PCI- Dabigatran
- ENTRUST AF PCI- Edoxaban
- AUGUSTUS-Apixaban
Last 3 ongoing studies as of 09/2017
Which trial showed Rivaroxaban reduced mortality post ACS
ATLAS ACS -2 TIMI 51
How to load Ticagrelor after Clopidogrel acute setting
180 mg
Irrespective of time and dose of Clopidogrel
If other way round loading Clopidogrel after Tica is 600mg AFTER 24 Hours of Tica
Interchange between Prasu and Clopidogrel in acute setting
Prasu 60 mg irrespective of Clopidogrel timing and dose
Clopidogrel loading 600mg AFTER 24 Hours of Prasu
Interchange between Prasu and Tica in acute setting
Tica 180 24 hours after Prasu
Prasu 60 24 hours after Tica
Same either way
ESC 2017
How to switch between Clop,Prasu,&;Tica in chronic setting
After Tica 24 hrs after loading dose load both clop and Pras
No loading for Tica
Between Clop and Pras . No loading dose . Normal dose after 24 hrs
In acute setting always give loading dose
Use of NOAC is discouraged in which VHD
Moderate-Severe Mitral stenosis
ESC 2017
Use of NOAC in AS/AR/MR
ESC 2017
IIa recommendation
GUSTO moderate bleeding criteria
Any bleeding which needs blood transfusions
Severe is IC Bleed & Any bleed which needs intervention For hemodynamic compromise
All others -Mild
Clopidogrel is the default antiplatelet post PCI only in
Stable CAD & Along with Oral anticoagulation
ESC 2017
Duration of DAPT in stable CAD
DES And BMS - both 1-6 monthsw
ESC2017
Duration of DAPT after ACS
12 months
6 months- If bleeding risk high
> 12 months-if ischemic Risk high
ESC2017
Duration of DAPT is not decided by stent type::This conclusion was by
I ESC2017
Duration of triple therapy after ACS if required is for
Only 6 months
ESC 2017
After Stenting (DES/BMS) Surgery is permitted after
1 month- If Aspirin can be continued
If both has to be stopped, bridge with
Cangrelor, Tirofiban or Eptifibatide
ESC 2017
Post CABG antiplatelets(after ACS)
DAPT for 1year
But role of DAPT after CABG for stable CAD is uncertain
ESC 2017
Triple therapy increases bleeding risk by
2-3 Times
Cangrelor half life and duration of action
10 mts- half life
2 hours- platelet function becomes normal
Tenecteplase is administered over
5 seconds
Position of Bivalirudin after ESC 2017
Downgraded from Class I To II a
Role of RBBB and LBBB in urgent CAG -ESC 2017
Equal
The ESC 2017 change in paradigm on DAPT
“DAPT is a regimen to treat the patient and not the previously implemented stent”
Ie individual patient’s ischemic risk versus bleeding risk
ESC 2017 recommendation on DAPT
12 months irrespective of revasc strategy
6 mon- If bleeding risk high
More than 12 mon - consider if no bleeding compln in 12 months
Addition of DAPT to OAC increase bleeding risk by
2-3 fold
ESC 2017
Duration of DAPT maximum should be 6 months
Use only Clopidogrel
Default P2Y12 in stable CAD treated with PCI
Clopidogrel
For ACS
Definition of HTN in CHADS2 VASc
BP >140/90 on at least two occasions
Definition of stroke in CHADS2 VASc score
Includes any thromboembolism also
Definition of Vascular disease in CHADS2 VASc score
MI, PAD, Aortic plaque
Varying coupling interval in VPCs indicate
Parasystole( not an extrasystole)
Two independent pacemakers functioning asynchronously . Can happen with extra systole also
If coupling interval is constant it means it’s a VPC arising from the same focus
Anticoagulant effect of Apixaban lasts for……..after last dose
24 hours - ie about 2 half lives
No established way to reverse the effect
When will you reduce the dose of apixaban to 2.5 mg BD
- Wt less than 60kg
- Creatinine-1.5
- Age-80
DAPT+ OAC increases bleeding complications by ……… times
2-3 Times compared to DAPT alone
Duration of triple therapy if indicated
Max 6 months or till Hospital discharge
Default P2Y12 in PCI
Stable CAD- Clopidogrel
ACS- Tica or Prasu
Triple therapy- Clopidogrel
ESC 2017
Risk factors for increased bleeding with DAPT
Prior h/o bleeding
Female ,Elderly,CRF
2015 PEGASUS trial is about
Ticagrelor in pts with prior MI- long term use
Studies which showed one month DAPT can be used in DES treated patients with better results than BMS
LEADERS FREE
ZEUS
Risk scoring tool for DAPT bleeding risk
PRECISE DAPT 2017
Direct acting P2Y12 inhibitors
Ticagrelor And Cangrelor
Difference in changing from Prasugrel to Ticagrelor in Early and Late (>30days) phase
In early phase- After 24 hrs of last Prasugrel- LD 180 mg
Late phase- After 24 hrs of last Prasugrel - 90 mg BID- MD
Prasugrel should be stopped how many days before surgery
Ticagrelor
Clopidogrel
P-7 days
Others- 5 days
How to change from Ticagrelor to Clopidogrel
600 mg LD-24 hrs after last T dose
Both in Early and Late phase
In the late ( more than 30 days after index event)clop/ prasu/ Tica switch :-loading dose is used only when
- Tica changed to Clopidogrel or
- Tica changed to Prasugrel
24 hrs from last Tica dose
600mg and 60 mg respectively
All other late switching is easy- Maintanence dose after 24 hrs
Early phase (30 days or less from index event)antiplatelet switching
For all it’s same. Give loading dose after 24 hours
Triple therapy strategy used in RE DUAL PCI trial
BMS- After 1 month Aspirin was stopped
DES-After 3
months Aspirin was stopped